AI Insight
Researchers at ETH Zurich have developed a light-activated molecular switch that targets and destroys stress hormone receptors in cancer cells. These receptors enable some cancer cells to enter a dormant state that allows them to survive treatment. Testing in laboratory lung cancer cells demonstrated that this approach can reawaken dormant tumor cells, potentially making them vulnerable to therapeutic intervention again.
Why it matters
This technique could enhance the effectiveness of cancer therapies by preventing tumor cells from escaping treatment through dormancy. The light-controlled precision of the approach may also reduce collateral damage to healthy tissue during treatment.
Understand the Science
Some cancer cells evade treatment by entering a dormant state triggered by stress hormones. ETH Zurich scientists have created a light-controlled molecular switch that selectively destroys the receptors responsible for this survival mode. In laboratory lung cancer cells, the approach woke sleeping tumor cells and could help make future cancer therapies more effective while minimizing damage to healthy tissue.
Source: Light switch wakes sleeping cancer cells and makes them vulnerable again